Billingham

CF Fertilisers UK Announces Proposal to Permanently Close Ammonia Plant at Billingham Complex

Retrieved on: 
火曜日, 7月 25, 2023
Other Manufacturing, Environment, Other Energy, Chemicals, Plastics, Manufacturing, Sustainability, Energy, Other Natural Resources, Natural Resources, Agriculture, Nitric acid, Billingham, CF Industries, CF, NYSE, Carbon, Ammonia, Fertilizer, Unite

CF Fertilisers UK Limited, a subsidiary of CF Industries Holdings, Inc. (NYSE: CF), today announced a proposal to permanently close the ammonia plant at its Billingham Complex in order to secure the long-term sustainability of its business in the United Kingdom (U.K.) and more efficiently serve its customers in the country.

Key Points: 
  • CF Fertilisers UK Limited, a subsidiary of CF Industries Holdings, Inc. (NYSE: CF), today announced a proposal to permanently close the ammonia plant at its Billingham Complex in order to secure the long-term sustainability of its business in the United Kingdom (U.K.) and more efficiently serve its customers in the country.
  • CF Fertilisers UK has made this proposal due to its forecast that producing ammonia at Billingham will not be cost-competitive for the long-term compared to importing ammonia due primarily to projected high natural gas prices in the United Kingdom relative to other regions and the impact of carbon costs.
  • Additionally, shutdowns in recent years of industrial customers’ U.K. operations that had consumed significant ammonia volumes for their businesses have created a supply-demand imbalance for ammonia production at the Billingham Complex.
  • The Company’s proposal to permanently close the ammonia plant at its Billingham Complex could result in up to 38 redundancies at the site, in relation to which it will be entering into the required collective redundancy consultation process with its recognised union, Unite, and elected employee representatives.

FUJIFILM Diosynth Biotechnologies Breaks Ground on Large-Scale Microbial Manufacturing Facility Expansion in Billingham, UK

Retrieved on: 
木曜日, 9月 22, 2022
Diosynth, FDA, A-DNA, Knowledge, PLUS, Industry, Fujifilm, Immortalised cell line, United Kingdom, Protein, Vaccine, CDMO, College Station, Mitsubishi Corporation, GLOBE, Triangle Park (Quezon City), Pharmaceutical industry, Fine chemical, UNITED KINGDOM, Billingham, Innovation

To accommodate the increasing demand for FUJIFILM Diosynth Biotechnologies microbial development and manufacturing services, the expansion will include over 1858 square meter (20,000 sq.

Key Points: 
  • To accommodate the increasing demand for FUJIFILM Diosynth Biotechnologies microbial development and manufacturing services, the expansion will include over 1858 square meter (20,000 sq.
  • Once the expansion is complete in late 2023/early 2024, the manufacturing capacity of the large-scale microbial production facility will increase by 70%.
  • This expansion is part of a previously announced 400 million planned investment package at FUJIFILM Diosynth Biotechnologies UK site, to expand cell culture capabilities, viral vector and gene therapy services, and microbial production.
  • 2 pAVEway PLUS is FUJIFILM Diosynth Biotechnologies proven microbial technology platform for efficient microbial expression of proteins, using novel recombinant E. coli strains.

CF Fertilisers UK Announces Intention to Temporarily Halt Ammonia Production at Billingham Complex; Company Will Import Ammonia to Produce AN Fertiliser and Nitric Acid at Site

Retrieved on: 
水曜日, 8月 24, 2022
Alternative Energy, Manufacturing, Energy, Other Energy, Chemicals, Plastics, CF, Plant, NYSE, AN, Carbon, Ammonia, CF Industries, Intention, CO2, Company, NBP, United Kingdom, Natural gas, Transport, Nitric acid, Fertilizer, Billingham

CF Fertilisers UK, a subsidiary of CF Industries Holdings, Inc. (NYSE: CF), today announced its intention to temporarily halt ammonia production at the Billingham Complex due to market conditions.

Key Points: 
  • CF Fertilisers UK, a subsidiary of CF Industries Holdings, Inc. (NYSE: CF), today announced its intention to temporarily halt ammonia production at the Billingham Complex due to market conditions.
  • CF Fertilisers UK intends to use the sites capability to import ammonia to enable it to continue to run its ammonium nitrate (AN) and nitric acid upgrade plants.
  • The Company expects to fulfil all ammonia and nitric acid contracts and all orders of AN contracted for delivery in the coming months.
  • The Company has notified customers who purchase carbon dioxide (CO2) on a contract basis from the Billingham Complex about the impending temporary halt of ammonia production.

CF Fertilisers UK Announces Proposals to Restructure Operations to Enable Continued Supply of Fertiliser, Carbon Dioxide and Other Industrial Products to Customers in the UK

Retrieved on: 
水曜日, 6月 8, 2022
Environment, Other Energy, Chemicals, Plastics, Manufacturing, Alternative Energy, Energy, Other Natural Resources, Agriculture, Natural Resources, Carbon dioxide, Time, Company, Legislation, CF Industries, Billingham, CF, Trustee, Government, Maintenance, Multimedia, Natural gas, DC, AN, Pension, NYSE, Ammonia, Plant, Kemira GrowHow, CO2, Nitric acid, Carbon, Food security, Oil, Fertilizer, Video game, Risk management, Retail, Ince, Unite

CF Fertilisers UK has sent notification to employees of the restructuring proposals and will be holding employee meetings over the next two days.

Key Points: 
  • CF Fertilisers UK has sent notification to employees of the restructuring proposals and will be holding employee meetings over the next two days.
  • The Company also has shared information about the proposals with Unite, which represents 442 CF Fertilisers UK employees, and with pension trustees.
  • CF Fertilisers UK will be submitting the relevant Form HR1 filings to the UK government today.
  • Since 2015, CF Industries has invested nearly 200 million of capital into CF Fertilisers UKs manufacturing facilities.

CF Industries Holdings, Inc. Announces Halt of Operations at UK Facilities

Retrieved on: 
水曜日, 9月 15, 2021
Other Energy, Utilities, Oil, Gas, Manufacturing, Alternative Energy, Energy, Other Manufacturing, NYSE, Transport, Billingham, Company, CF Industries, Ammonia, CF, United Kingdom, Hydrogen, Oil

CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer of hydrogen and nitrogen products, today announced that it is halting operations at both its Billingham and Ince, UK, manufacturing complexes due to high natural gas prices.

Key Points: 
  • CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer of hydrogen and nitrogen products, today announced that it is halting operations at both its Billingham and Ince, UK, manufacturing complexes due to high natural gas prices.
  • The Company does not have an estimate for when production will resume at the facilities.
  • At CF Industries, our mission is to provide clean energy to feed and fuel the world sustainably.
  • CF Industries routinely posts investor announcements and additional information on the companys website at www.cfindustries.com and encourages those interested in the company to check there frequently.

FUJIFILM Corporation Announces the Introduction of a Novel, Fully Integrated Continuous Production System for the Manufacture of Biopharmaceuticals

Retrieved on: 
水曜日, 6月 5, 2019
Diosynth, Oss, Fujifilm, Billingham, Optics, Companies, Economy of Japan

TOKYO, June 5, 2019 /PRNewswire/ --FUJIFILM Corporation (President: Kenji Sukeno), today announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its FUJIFILM Diosynth Biotechnologies, Billingham, UK location.

Key Points: 
  • TOKYO, June 5, 2019 /PRNewswire/ --FUJIFILM Corporation (President: Kenji Sukeno), today announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its FUJIFILM Diosynth Biotechnologies, Billingham, UK location.
  • Perfusion is a cell culturemanufacturing process that involves the constant feeding of fresh media and processing of harvested media over several weeks.
  • Fujifilm has developed an in-house, defined medium suitable for very high density perfusion culture and has adapted its ApolloX cell line for perfusion processing.
  • FUJIFILM Diosynth Biotechnologies is a partnership between FUJIFILM Corporation and Mitsubishi Corporation.

FUJIFILM Corporation Announces the Introduction of a Novel, Fully Integrated Continuous Production System for the Manufacture of Biopharmaceuticals

Retrieved on: 
水曜日, 6月 5, 2019
Diosynth, Oss, Fujifilm, Billingham, Optics, Companies, Economy of Japan

TOKYO, June 5, 2019 /PRNewswire/ --FUJIFILM Corporation (President: Kenji Sukeno), today announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its FUJIFILM Diosynth Biotechnologies, Billingham, UK location.

Key Points: 
  • TOKYO, June 5, 2019 /PRNewswire/ --FUJIFILM Corporation (President: Kenji Sukeno), today announced an initial $10M USD investment to establish a full scale, fully integrated continuous processing facility for non-GMP manufacture of biopharmaceuticals at its FUJIFILM Diosynth Biotechnologies, Billingham, UK location.
  • Perfusion is a cell culturemanufacturing process that involves the constant feeding of fresh media and processing of harvested media over several weeks.
  • Fujifilm has developed an in-house, defined medium suitable for very high density perfusion culture and has adapted its ApolloX cell line for perfusion processing.
  • FUJIFILM Diosynth Biotechnologies is a partnership between FUJIFILM Corporation and Mitsubishi Corporation.